glutamine has been researched along with Dermatitis, Atopic in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Holeček, M | 1 |
Abbott, JK; Arjunaraja, S; Bernasconi, AR; Cooper, MA; Danielian, S; DiMaggio, T; Dorjbal, B; Dubra, G; Gelfand, EW; Glauzy, S; Hauk, PJ; Jones, N; Kim, B; Lyons, JJ; Ma, CA; Marti, MA; Matthews, HF; McElwee, JJ; Meffre, E; Milner, JD; Nelson, CG; Niemela, J; Oleastro, M; Palma, A; Prieto, E; Reynolds, PR; Romberg, N; Rosenzweig, SD; Ruffo, E; Snow, AL; Stinson, JR; Stoddard, J; Stone, KD; Voss, K; Weinreich, MA; Yamakawa, N; Zaiat, J; Zhang, Y | 1 |
Fetter, WP; Nieuwenhuis, EE; Twisk, JW; van den Berg, A; van Elburg, RM; van Zwol, A | 1 |
Fetter, WP; Knol, J; Twisk, JW; Van Den Berg, A; Van Elburg, RM; Van Zwol, A | 1 |
Fetter, WP; Moll, HA; van Elburg, RM; van Zwol, A | 1 |
Fetter, WP; Moll, HA; van den Berg, A; van Elburg, RM; van Zwol, A | 1 |
Brand, S; Dalpke, AH; Draing, C; Frey, M; Heeg, K; Mrabet-Dahbi, S; Niebuhr, M; Renz, H; Werfel, T | 1 |
1 review(s) available for glutamine and Dermatitis, Atopic
Article | Year |
---|---|
Histidine in Health and Disease: Metabolism, Physiological Importance, and Use as a Supplement.
Topics: Amino Acids, Branched-Chain; Ammonia; Chelating Agents; Contraindications; Dermatitis, Atopic; Dietary Supplements; Filaggrin Proteins; Free Radical Scavengers; Glutamine; Histamine; Histidine; Humans; Hypertrophy; Liver; Liver Diseases; Metabolic Syndrome; Nervous System Diseases; Organ Preservation Solutions | 2020 |
2 trial(s) available for glutamine and Dermatitis, Atopic
Article | Year |
---|---|
Cytokine profiles in 1-yr-old very low-birth-weight infants after enteral glutamine supplementation in the neonatal period.
Topics: Adult; Cohort Studies; Communicable Diseases; Cytokines; Dermatitis, Atopic; Enteral Nutrition; Female; Follow-Up Studies; Glutamine; Humans; Incidence; Infant; Infant, Newborn; Infant, Very Low Birth Weight; Male; Th1 Cells; Th2 Cells; Treatment Outcome; Young Adult | 2009 |
Glutamine-enriched enteral nutrition in very low-birth-weight infants: effect on the incidence of allergic and infectious diseases in the first year of life.
Topics: Bronchial Hyperreactivity; Communicable Diseases; Dermatitis, Atopic; Enteral Nutrition; Follow-Up Studies; Glutamine; Humans; Hypersensitivity; Incidence; Infant; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Logistic Models; Respiration, Artificial; Risk Assessment | 2007 |
4 other study(ies) available for glutamine and Dermatitis, Atopic
Article | Year |
---|---|
Germline hypomorphic CARD11 mutations in severe atopic disease.
Topics: Amino Acid Transport System ASC; CARD Signaling Adaptor Proteins; Cohort Studies; Dermatitis, Atopic; DNA Mutational Analysis; Female; Genes, Dominant; Germ-Line Mutation; Glutamine; Guanylate Cyclase; Humans; Jurkat Cells; Lymphocyte Activation; Male; Mechanistic Target of Rapamycin Complex 1; Minor Histocompatibility Antigens; Multiprotein Complexes; NF-kappa B; Pedigree; T-Lymphocytes; TOR Serine-Threonine Kinases | 2017 |
Intestinal microbiota in allergic and nonallergic 1-year-old very low birth weight infants after neonatal glutamine supplementation.
Topics: Bifidobacterium; Case-Control Studies; Clostridium; Clostridium histolyticum; Dermatitis, Atopic; Dietary Supplements; Enteral Nutrition; Escherichia coli; Feces; Female; Follow-Up Studies; Glutamine; Humans; Infant; Infant Nutritional Physiological Phenomena; Infant, Newborn; Infant, Very Low Birth Weight; Intestines; Male; Metagenome; Surveys and Questionnaires | 2010 |
Glutamine-enriched enteral nutrition in very low birthweight infants and allergic and infectious diseases at 6 years of age.
Topics: Child; Communicable Diseases; Dermatitis, Atopic; Dietary Supplements; Enteral Nutrition; Follow-Up Studies; Gastrointestinal Diseases; Glutamine; Humans; Hypersensitivity; Infant, Newborn; Infant, Very Low Birth Weight; Randomized Controlled Trials as Topic; Regression Analysis; Risk Assessment; Surveys and Questionnaires; Urologic Diseases | 2011 |
The Toll-like receptor 2 R753Q mutation modifies cytokine production and Toll-like receptor expression in atopic dermatitis.
Topics: Amino Acid Substitution; Arginine; Cell Line; Cytokines; Dermatitis, Atopic; Gene Expression Regulation; Genetic Carrier Screening; Glutamine; Humans; Immunity, Innate; Mutagenesis, Site-Directed; Mutation; Polymorphism, Single Nucleotide; RNA, Messenger; Toll-Like Receptor 2; Toll-Like Receptor 6 | 2008 |